Selected research
Market Structure
Global Urinary and Pelvic Floor Health Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Urinary and Pelvic Floor Health Solution market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Urinary and Pelvic Floor Health Solution is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Urinary and Pelvic Floor Health Solution include Peloton Health, Elvie, Renovia, InControl Medical, PeriCoach, NeoTract, NextGen Jane, Hollister Incorporated and Zimmer Biomet, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Urinary and Pelvic Floor Health Solution market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Urinary and Pelvic Floor Health Solution and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Urinary and Pelvic Floor Health Solution revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Urinary and Pelvic Floor Health Solution market size, projected growth trends, production technologies, key applications, and end-use industries.
Urinary and Pelvic Floor Health Solution Segment by Company
Peloton Health
Elvie
Renovia
InControl Medical
PeriCoach
NeoTract
NextGen Jane
Hollister Incorporated
Zimmer Biomet
Joylux
Medtronic
Atlantic Therapeutics
Boston Scientific
Urinary and Pelvic Floor Health Solution Segment by Type
Urology and Pelvic Floor Health Software
Urology and Pelvic Floor Health Service
Urinary and Pelvic Floor Health Solution Segment by Application
Male
Female
Urinary and Pelvic Floor Health Solution Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary and Pelvic Floor Health Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Urinary and Pelvic Floor Health Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary and Pelvic Floor Health Solution.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Urinary and Pelvic Floor Health Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Urinary and Pelvic Floor Health Solution industry.
Chapter 3: Detailed analysis of Urinary and Pelvic Floor Health Solution companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urinary and Pelvic Floor Health Solutionrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Urology and Pelvic Floor Health Software
- Urology and Pelvic Floor Health Service
Applications
- Male
- Female
Companies covered
- Peloton Health
- Elvie
- Renovia
- InControl Medical
- PeriCoach
- NeoTract
- NextGen Jane
- Hollister Incorporated
- Zimmer Biomet
- Joylux
- Medtronic
- Atlantic Therapeutics
- Boston Scientific
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Urology and Pelvic Floor Health Software
- 1.2.3 Urology and Pelvic Floor Health Service
- 1.3 Market Analysis by Application
- 1.3.1 Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Male
- 1.3.3 Female
- 1.4 Global Market Growth Prospects
- 1.5 Global Urinary and Pelvic Floor Health Solution Growth Trends by Region
- 1.5.1 Global Urinary and Pelvic Floor Health Solution Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Urinary and Pelvic Floor Health Solution Market Size by Region (2021-2026)
- 1.5.3 Urinary and Pelvic Floor Health Solution Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Urinary and Pelvic Floor Health Solution Market Dynamics
- 2.1 Urinary and Pelvic Floor Health Solution Industry Trends
- 2.2 Urinary and Pelvic Floor Health Solution Industry Drivers
- 2.3 Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges
- 2.4 Urinary and Pelvic Floor Health Solution Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Urinary and Pelvic Floor Health Solution Revenue by Company (2021-2026)
- 3.2 Global Urinary and Pelvic Floor Health Solution Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Urinary and Pelvic Floor Health Solution Key Company Head office and Area Served
- 3.4 Global Urinary and Pelvic Floor Health Solution Company, Product Type & Application
- 3.5 Global Urinary and Pelvic Floor Health Solution Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Urinary and Pelvic Floor Health Solution Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Urinary and Pelvic Floor Health Solution Players Market Share by Revenue in 2025
- 3.6.3 2025 Urinary and Pelvic Floor Health Solution Tier 1, Tier 2, and Tier 3
4 Urinary and Pelvic Floor Health Solution Market by Type
- 4.1 Global Urinary and Pelvic Floor Health Solution Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2032)
- 4.3 Global Urinary and Pelvic Floor Health Solution Market Size Share by Type (2021-2032)
5 Urinary and Pelvic Floor Health Solution Market by Application
- 5.1 Global Urinary and Pelvic Floor Health Solution Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2032)
- 5.3 Global Urinary and Pelvic Floor Health Solution Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Peloton Health
- 6.1.1 Peloton Health Company Information
- 6.1.2 Peloton Health Business Overview
- 6.1.3 Peloton Health Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.1.5 Peloton Health Recent Developments
- 6.2 Elvie
- 6.2.1 Elvie Company Information
- 6.2.2 Elvie Business Overview
- 6.2.3 Elvie Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Elvie Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.2.5 Elvie Recent Developments
- 6.3 Renovia
- 6.3.1 Renovia Company Information
- 6.3.2 Renovia Business Overview
- 6.3.3 Renovia Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Renovia Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.3.5 Renovia Recent Developments
- 6.4 InControl Medical
- 6.4.1 InControl Medical Company Information
- 6.4.2 InControl Medical Business Overview
- 6.4.3 InControl Medical Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.4.5 InControl Medical Recent Developments
- 6.5 PeriCoach
- 6.5.1 PeriCoach Company Information
- 6.5.2 PeriCoach Business Overview
- 6.5.3 PeriCoach Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.5.5 PeriCoach Recent Developments
- 6.6 NeoTract
- 6.6.1 NeoTract Company Information
- 6.6.2 NeoTract Business Overview
- 6.6.3 NeoTract Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.6.5 NeoTract Recent Developments
- 6.7 NextGen Jane
- 6.7.1 NextGen Jane Company Information
- 6.7.2 NextGen Jane Business Overview
- 6.7.3 NextGen Jane Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.7.5 NextGen Jane Recent Developments
- 6.8 Hollister Incorporated
- 6.8.1 Hollister Incorporated Company Information
- 6.8.2 Hollister Incorporated Business Overview
- 6.8.3 Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.8.5 Hollister Incorporated Recent Developments
- 6.9 Zimmer Biomet
- 6.9.1 Zimmer Biomet Company Information
- 6.9.2 Zimmer Biomet Business Overview
- 6.9.3 Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.9.5 Zimmer Biomet Recent Developments
- 6.10 Joylux
- 6.10.1 Joylux Company Information
- 6.10.2 Joylux Business Overview
- 6.10.3 Joylux Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Joylux Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.10.5 Joylux Recent Developments
- 6.11 Medtronic
- 6.11.1 Medtronic Company Information
- 6.11.2 Medtronic Business Overview
- 6.11.3 Medtronic Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.11.5 Medtronic Recent Developments
- 6.12 Atlantic Therapeutics
- 6.12.1 Atlantic Therapeutics Company Information
- 6.12.2 Atlantic Therapeutics Business Overview
- 6.12.3 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.12.5 Atlantic Therapeutics Recent Developments
- 6.13 Boston Scientific
- 6.13.1 Boston Scientific Company Information
- 6.13.2 Boston Scientific Business Overview
- 6.13.3 Boston Scientific Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio
- 6.13.5 Boston Scientific Recent Developments
7 North America
- 7.1 North America Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 7.2 North America Urinary and Pelvic Floor Health Solution Market Size by Type
- 7.2.1 North America Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2026)
- 7.2.2 North America Urinary and Pelvic Floor Health Solution Market Size by Type (2027-2032)
- 7.2.3 North America Urinary and Pelvic Floor Health Solution Market Share by Type (2021-2032)
- 7.3 North America Urinary and Pelvic Floor Health Solution Market Size by Application
- 7.3.1 North America Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2026)
- 7.3.2 North America Urinary and Pelvic Floor Health Solution Market Size by Application (2027-2032)
- 7.3.3 North America Urinary and Pelvic Floor Health Solution Market Share by Application (2021-2032)
- 7.4 North America Urinary and Pelvic Floor Health Solution Market Size by Country
- 7.4.1 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 7.4.3 North America Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 7.4.4 North America Urinary and Pelvic Floor Health Solution Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 8.2 Europe Urinary and Pelvic Floor Health Solution Market Size by Type
- 8.2.1 Europe Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2026)
- 8.2.2 Europe Urinary and Pelvic Floor Health Solution Market Size by Type (2027-2032)
- 8.2.3 Europe Urinary and Pelvic Floor Health Solution Market Share by Type (2021-2032)
- 8.3 Europe Urinary and Pelvic Floor Health Solution Market Size by Application
- 8.3.1 Europe Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2026)
- 8.3.2 Europe Urinary and Pelvic Floor Health Solution Market Size by Application (2027-2032)
- 8.3.3 Europe Urinary and Pelvic Floor Health Solution Market Share by Application (2021-2032)
- 8.4 Europe Urinary and Pelvic Floor Health Solution Market Size by Country
- 8.4.1 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 8.4.3 Europe Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 8.4.4 Europe Urinary and Pelvic Floor Health Solution Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 9.2 China Urinary and Pelvic Floor Health Solution Market Size by Type
- 9.2.1 China Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2026)
- 9.2.2 China Urinary and Pelvic Floor Health Solution Market Size by Type (2027-2032)
- 9.2.3 China Urinary and Pelvic Floor Health Solution Market Share by Type (2021-2032)
- 9.3 China Urinary and Pelvic Floor Health Solution Market Size by Application
- 9.3.1 China Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2026)
- 9.3.2 China Urinary and Pelvic Floor Health Solution Market Size by Application (2027-2032)
- 9.3.3 China Urinary and Pelvic Floor Health Solution Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 10.2 Asia Urinary and Pelvic Floor Health Solution Market Size by Type
- 10.2.1 Asia Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2026)
- 10.2.2 Asia Urinary and Pelvic Floor Health Solution Market Size by Type (2027-2032)
- 10.2.3 Asia Urinary and Pelvic Floor Health Solution Market Share by Type (2021-2032)
- 10.3 Asia Urinary and Pelvic Floor Health Solution Market Size by Application
- 10.3.1 Asia Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2026)
- 10.3.2 Asia Urinary and Pelvic Floor Health Solution Market Size by Application (2027-2032)
- 10.3.3 Asia Urinary and Pelvic Floor Health Solution Market Share by Application (2021-2032)
- 10.4 Asia Urinary and Pelvic Floor Health Solution Market Size by Country
- 10.4.1 Asia Urinary and Pelvic Floor Health Solution Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 10.4.3 Asia Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 10.4.4 Asia Urinary and Pelvic Floor Health Solution Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Type
- 11.2.1 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Application
- 11.3.1 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country
- 11.4.1 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Urinary and Pelvic Floor Health Solution Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst